27.09.2013 Views

Springer, Encyclopedic Reference Of Cancer (2001) Ocr 7.0 Lotb.pdf

Springer, Encyclopedic Reference Of Cancer (2001) Ocr 7.0 Lotb.pdf

Springer, Encyclopedic Reference Of Cancer (2001) Ocr 7.0 Lotb.pdf

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

606 Mutator Phenotype<br />

nance of genetic stability. Among the many<br />

mutations produced are ones that promote<br />

growth, invasion and metastasis, the hallmarks<br />

of cancer.<br />

Characteristics<br />

Mutations and cancer<br />

The ability of cancer cells to continually mutate<br />

may be central to how tumors evolve. In the<br />

case of solid tumors, there is approximately a<br />

twenty-year interval from the exposure of an<br />

individual to a carcinogen until the clinical detection<br />

of a tumor. During this interval, cancer<br />

cells acquire properties that allow them to<br />

flourish in a changing environment. By the<br />

time a tumor is detectable, the cancer cells<br />

are able to divide where normal cells do not,<br />

to invade adjacent cellular architectures, to metastasize<br />

and eventually to kill the host. In addition,<br />

tumors have the capacity to rapidly develop<br />

resistance to a variety of chemotherapeutic<br />

agents. Each of these phenotypes can be mimicked<br />

by mutations in normal cells.<br />

Chromosomal alterations in human cancers<br />

Mutations can be defined as a change in the nucleotide<br />

sequence in DNA. Mutations in cancer<br />

cells cover a wide spectrum from chromosomal<br />

alterations that encompasses millions of nucleotides<br />

to point mutations that involve only<br />

a few nucleotide substitutions in single genes.<br />

Multiple somatic chromosomal alterations<br />

are diagnostically associated with cancer cells<br />

and involve translocations, deletions, amplifications<br />

and aneuploidy (a change in the number<br />

of chromosomes in individual cells). Unique<br />

chromosomal changes occur at high frequencies<br />

in certain tumors and are of diagnostic<br />

significance. However, there is a striking heterogeneity<br />

of chromosomal alterations in cancer<br />

cells within individual tumors. In general,<br />

there is a positive correlation between the number<br />

of chromosomal changes within a tumor<br />

and the malignant potential of that tumor.<br />

As molecular techniques are becoming more<br />

sensitive, more and more chromosomal abnormalities<br />

are being reported in different tu-<br />

mors. In some tumors there is evidence for a<br />

sequential order in chromosomal mutations<br />

during tumor progressions. Measurements of<br />

the number of copies of segments of the genome<br />

in tumor cells (DNA copy number) and<br />

the loss of pieces of DNA (loss of heterozygosity)<br />

have established that many tumors harbor<br />

as many as 40 chromosomal alterations. It<br />

should be emphasized that these methodologies<br />

only score a very small fraction of the genome<br />

and as a result may greatly underestimate<br />

the number of small chromosomal rearrangements<br />

within the genome.<br />

Point mutations in human cancer<br />

Only recently has evidence accumulated indicating<br />

that cancer cells not only contain multiple<br />

chromosomal alterations, but also contain<br />

thousands of smaller changes in nucleotide sequence.<br />

These studies have provided strong<br />

support of the mutator phenotype hypothesis<br />

involving a reduction in the fidelity of DNA replication<br />

and/or a decrease in the efficiency of<br />

DNA repair. An early clue to the large numbers<br />

of mutations in cancer cells was the observations<br />

that the resistance of cancer cell lines<br />

to divergent chemotherapies was mediated by<br />

gene amplification. The first direct evidence<br />

in support of a mutator phenotype in cancer<br />

was provided by the demonstration that cells<br />

from patients with HNPCC (hereditary nonpolyposis<br />

colon cancer) exhibit microsatellite<br />

instability in association with mutations in<br />

DNA repair genes. Microsatellites are short repetitive<br />

sequences of nucleotides in DNA that<br />

are subjected to slippage during copying by<br />

DNA polymerases. In normal individuals, mutations<br />

in microsatellites are corrected by the<br />

DNA mismatch repair system. In HNPCC tumors,<br />

the deficits in mismatch repair result<br />

in expansions and contractions in the length<br />

of repetitive nucleotide sequences. Based on<br />

the enormous number of microsatellites in<br />

the human genome, it has been calculated<br />

that each tumor could harbor more than<br />

100,000 mutations in these sequences alone. Repetitive<br />

sequences located within genes are also<br />

mutated at high frequencies in these tumors.<br />

Changes in the lengths of repetitive sequences

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!